Funding Opportunity PAR-20-267 from the NIH Guide for Grants and Contracts. NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators , and share findings, data and their resources, consistent with achieving the goals of the program.

Funding Opportunity PAR-20-269 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain comprehensive mechanistic understanding of the impact of sex differences on the trajectories of brain aging, phenotypes, and risk of Alzheimer's Disease (AD) and AD-related dementia (ADRD), and on precision medicine for treatment and prevention of AD/ADRD, including the responsiveness to pharmacologic and non-pharmacologic interventions.

F. Hoffmann-La Roche AG: As a (Associate)/Group Director within our Personalized HealthCare function you will be responsible for the data science strategies, and lead a Switzerland (CH)

Funding Opportunity RFA-DA-21-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA isto develop tools and technologies to conduct cientifically rigorous, ethical, efficient, and cost-effective research infrastructure that supports germline and somatic transgenic and gene editing studies in the common marmoset (Callithrix jacchus). These studies should to answer crucial scientific questions that require genetic perturbation in a non-human primate model organism with the aim of supporting BRAIN goals of understanding the brain in health an disease.

£32,235 - £35,709 per annum: Animal and Plant Health Agency: The Animal and Plant Health Agency (APHA) is an executive agency of the Department for Environment, Food & Rural Affairs..... New Haw, Addlestone

Notice NOT-MH-20-071 from the NIH Guide for Grants and Contracts

Notice NOT-AT-20-020 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-133 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-136 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-137 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-134 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-135 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-788 from the NIH Guide for Grants and Contracts

The successful candidate should be able to design, develop, test and run analysis tools under supervision of senior faculty, project bioinformaticians, and…
From Medical College of Wisconsin - Thu, 16 Jul 2020 15:09:03 GMT - View all Milwaukee, WI jobs

Independently conducts data curation including data acquisition and analysis for research projects whose focus is to provide comprehensive disease, clinical and…
From Medical College of Wisconsin - Thu, 16 Jul 2020 15:08:26 GMT - View all Milwaukee, WI jobs

94k-118k: Hudson Shribman: With a strong background in biological sciences, pharmacology or toxicology you will lead the biological science efficacy assessment of products South East England (GB)

Funding Opportunity RFA-CA-20-045 from the NIH Guide for Grants and Contracts. This limited competition Funding Opportunity Announcement (FOA) solicits the renewal application for the International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Hazards to Humans. The IARC Monographs program, which is supported in part by the NCI, critically evaluates the published scientific evidence on carcinogenic hazards to humans. Monograph volumes are considered critical references that inform health policy and cancer research worldwide about carcinogenic hazards to reduce cancer burden globally.

Notice NOT-NR-20-006 from the NIH Guide for Grants and Contracts

Notice NOT-AT-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-075 from the NIH Guide for Grants and Contracts